Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166

Showing 51-75 of 166 citing articles:

Phencyclidine-Based New Psychoactive Substances
Jason Wallach, Simon D. Brandt
Handbook of experimental pharmacology (2018), pp. 261-303
Closed Access | Times Cited: 31
1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
Jason Wallach, Simon D. Brandt
Handbook of experimental pharmacology (2018), pp. 305-352
Closed Access | Times Cited: 31
A case report SPECT study and theoretical rationale for the sequential administration of ibogaine and 5-MeO-DMT in the treatment of alcohol use disorder
Joseph P. Barsuglia, Martín Polanco, Robert L. Palmer, et al.
Progress in brain research (2018), pp. 121-158
Closed Access | Times Cited: 30
Understanding Central Nervous System Effects of Deliriant Hallucinogenic Drugs through Experimental Animal Models
Andrey D. Volgin, Oleg A. Yakovlev, Konstantin A. Demin, et al.
ACS Chemical Neuroscience (2018) Vol. 10, Iss. 1, pp. 143-154
Closed Access | Times Cited: 29
Auditory System Target Engagement During Plasticity-Based Interventions in Schizophrenia: A Focus on Modulation of N-Methyl-D-Aspartate–Type Glutamate Receptor Function
Joshua T. Kantrowitz, Neal R. Swerdlow, Walter Dunn, et al.
Biological Psychiatry Cognitive Neuroscience and Neuroimaging (2018) Vol. 3, Iss. 7, pp. 581-590
Open Access | Times Cited: 28
Memantine can improve chronic ethanol exposure-induced spatial memory impairment in male C57BL/6 mice by reducing hippocampal apoptosis
Xiaolong Wang, Hao Yu, Jiabin You, et al.
Toxicology (2018) Vol. 406-407, pp. 21-32
Closed Access | Times Cited: 28
Repurposing of Drugs–The Ketamine Story
Joydip Das
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 22, pp. 13514-13525
Closed Access | Times Cited: 25
Neuronal correlates of ketamine and walking induced gamma oscillations in the medial prefrontal cortex and mediodorsal thalamus
Katrina Furth, Airlie J. McCoy, Caroline Dodge, et al.
PLoS ONE (2017) Vol. 12, Iss. 11, pp. e0186732-e0186732
Open Access | Times Cited: 27
The 1980s: d-AP5, LTP and a Decade of NMDA Receptor Discoveries
David Lodge, J. C. Watkins, Z A Bortolotto, et al.
Neurochemical Research (2018) Vol. 44, Iss. 3, pp. 516-530
Open Access | Times Cited: 27
Disturbances of novel object exploration and recognition in a chronic ketamine mouse model of schizophrenia
Maria Jelena Hauser, Dirk Isbrandt, Jochen Roeper
Behavioural Brain Research (2017) Vol. 332, pp. 316-326
Closed Access | Times Cited: 26
Effects of N-Methyl-D-aspartate (NMDA) antagonists ketamine, methoxetamine, and phencyclidine on the odor span test of working memory in rats.
Michael Mathews, Ralph N. Mead, Mark Galizio
Experimental and Clinical Psychopharmacology (2018) Vol. 26, Iss. 1, pp. 6-17
Open Access | Times Cited: 26
Ephenidine: A new psychoactive agent with ketamine-like NMDA receptor antagonist properties
Heather Kang, Pojeong Park, Zuner A. Bortolotto, et al.
Neuropharmacology (2016) Vol. 112, pp. 144-149
Open Access | Times Cited: 24
Refractory anti-NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review
Serena Marita Lazzarin, Marco Vabanesi, Giordano Cecchetti, et al.
Journal of Neurology (2020) Vol. 267, Iss. 8, pp. 2462-2468
Closed Access | Times Cited: 21
Ketamine Treatment for Depression in Patients With a History of Psychosis or Current Psychotic Symptoms
Jolien K. E. Veraart, Sanne Y. Smith-Apeldoorn, Jan Spijker, et al.
The Journal of Clinical Psychiatry (2021) Vol. 82, Iss. 4
Open Access | Times Cited: 18
N-methyl-D-aspartate receptor hypofunction as a potential contributor to the progression and manifestation of many neurological disorders
Bin Dong, Yue Yang, Dong Han, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice
Patrícia Zorzi Juliani, Talita Rodrigues, Getúlio Nicola Bressan, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 971-986
Closed Access | Times Cited: 2
Newer propofol, ketamine, and etomidate derivatives and delivery systems relevant to anesthesia practice
Niels Hulsman, Markus W. Hollmann, Benedikt Preckel
Best Practice & Research Clinical Anaesthesiology (2018) Vol. 32, Iss. 2, pp. 213-221
Closed Access | Times Cited: 23
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studies
Jeffrey M. Witkin, Ryan A. Shenvi, Xia Li, et al.
Biochemical Pharmacology (2018) Vol. 155, pp. 61-70
Open Access | Times Cited: 22
Newly Emerging Drugs of Abuse
Kenichi Tamama, Michael J. Lynch
Handbook of experimental pharmacology (2019), pp. 463-502
Closed Access | Times Cited: 20
The effect of lansoprazole on MK-801-induced schizophrenia-like behaviors in mice
Hyo Jeoung Bae, Ho Jung Bae, Jae Youn Kim, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 120, pp. 110646-110646
Closed Access | Times Cited: 11
Designer drugs: Review and implications for emergency management
Ali Pourmand, Maryann Mazer‐Amirshahi, Sonya Chistov, et al.
Human & Experimental Toxicology (2017) Vol. 37, Iss. 1, pp. 94-101
Open Access | Times Cited: 21
Comparative Pharmacological Study of Common NMDA Receptor Open Channel Blockers Regarding Their Affinity and Functional Activity toward GluN2A and GluN2B NMDA Receptors
Louisa Temme, Dirk Schepmann, Julian A. Schreiber, et al.
ChemMedChem (2018) Vol. 13, Iss. 5, pp. 446-452
Closed Access | Times Cited: 19
Modulating synaptic NMDA receptors
Kenneth R. Tovar, Gary L. Westbrook
Neuropharmacology (2016) Vol. 112, pp. 29-33
Open Access | Times Cited: 18
Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia
Maxime Veleanu, Beetsi Urrieta-Chávez, Séverine M. Sigoillot, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 21
Open Access | Times Cited: 10
Prodromal headache in anti‐NMDAR encephalitis: An epiphenomenon of NMDAR autoimmunity
Naomi Tominaga, Naomi Kanazawa, Atsushi Kaneko, et al.
Brain and Behavior (2018) Vol. 8, Iss. 7
Open Access | Times Cited: 18

Scroll to top